Impact of systemic diseases on oral health and facial surgery outcomes

INTRODUCTION

Systemic diseases significantly influence oral health and facial surgery outcomes, a topic that has garnered increasing attention over the past few decades. The complex interplay between systemic health conditions and oral diseases such as periodontitis has been well-documented, emphasizing the need for a holistic approach in dental care and maxillofacial surgery. Systemic diseases such as diabetes, cardiovascular disease, and immune disorders often exacerbate oral health problems and complicate facial surgeries. This correlation is particularly evident in the periodontal response to systemic conditions and the healing processes following maxillofacial surgical interventions.¹

Diabetes, for instance, is one of the most well-studied systemic conditions linked to poor oral health. Uncontrolled diabetes contributes to increased periodontal disease severity, delayed wound healing, and greater risk of infection following surgical procedures. The elevated blood glucose levels in diabetic patients impair neutrophil function and collagen production, which are crucial for periodontal health and post-surgical recovery.² Additionally, patients with cardiovascular diseases face increased risks during oral and maxillofacial procedures, as the systemic inflammatory response triggered by periodontal disease can exacerbate cardiovascular conditions.³ This creates a two-way relationship between oral health and systemic disease, where one impacts the other in both directions.

Another key factor is the role of immune suppression, which often arises in patients with conditions such as human immunodeficiency virus/acquired immune deficiency syndrome (HIV/AIDS) or those undergoing treatments like chemotherapy. Immunocompromised individuals are at greater risk for infections, making them more susceptible to oral diseases such as periodontitis. These patients also tend to experience delayed wound healing, posing significant challenges for maxillofacial surgeons.⁴ The immune system’s role in managing oral health and surgical recovery cannot be understated, as adequate immune response is essential for both fighting infections and promoting tissue repair after surgical interventions. Given the increasing prevalence of systemic diseases worldwide, particularly in aging populations, the relationship between these diseases and oral health must be further explored. This review aims to examine the impact of various systemic diseases on both periodontal health and maxillofacial surgery outcomes, with a focus on understanding how systemic health conditions complicate dental and surgical treatments, and how clinicians can better manage these challenges in practice.

REVIEW

The relationship between systemic diseases and oral health is multifaceted, particularly in the context of periodontics and maxillofacial surgery. Systemic conditions such as diabetes and cardiovascular disease not only worsen periodontal health but also increase the complexity of surgical interventions. Diabetic patients, for instance, exhibit delayed wound healing and an increased risk of post-surgical infections due to impaired collagen production and reduced immune function.⁵ These complications pose significant challenges in both periodontal management and surgical procedures, necessitating specialized treatment protocols for diabetic patients undergoing maxillofacial surgeries.

Cardiovascular diseases, such as atherosclerosis, also complicate dental treatments by elevating the risk of systemic inflammation triggered by periodontal disease.⁶ This systemic inflammatory response can worsen cardiovascular conditions, underscoring the importance of comprehensive medical management in patients with concurrent oral health issues and cardiovascular disease. Similarly, immunocompromised patients, such as those with HIV or undergoing chemotherapy, face heightened risks of periodontal disease and poor surgical outcomes due to impaired immune responses, which are essential for both infection control and wound healing. Therefore, managing oral health in patients with systemic diseases requires an interdisciplinary approach that considers both the oral manifestations and systemic complications to optimize treatment outcomes in periodontal and surgical care.

Influence of systemic diseases on periodontal health and disease progression

Systemic diseases such as diabetes, cardiovascular disease, and osteoporosis have a profound impact on periodontal health, contributing to the progression of periodontal disease and complicating treatment outcomes. Diabetes mellitus, in particular, has been extensively studied in relation to periodontal disease. Diabetic patients exhibit a higher prevalence of periodontitis due to their impaired immune response, characterized by reduced neutrophil function and collagen synthesis, which are critical for maintaining periodontal health. Elevated blood glucose levels create an environment conducive to increased inflammation and delayed healing, exacerbating periodontal disease progression. Studies have shown that patients with poor glycemic control are more likely to suffer from severe periodontitis, making diabetes a major risk factor in periodontal disease progression.⁷

Cardiovascular diseases are also closely linked to periodontal health, with inflammation playing a central role in both conditions. Chronic periodontal infection triggers systemic inflammatory responses, which can aggravate cardiovascular conditions such as atherosclerosis. Research suggests that periodontal pathogens may enter the bloodstream, contributing to the formation of atherosclerotic plaques and promoting vascular inflammation. This bidirectional relationship underscores the importance of managing periodontal health to reduce the risk of cardiovascular events, as periodontal inflammation may further elevate systemic inflammatory markers such as C-reactive protein.³ The presence of periodontitis in individuals with cardiovascular disease has been associated with poorer prognoses, indicating the necessity of integrated care that addresses both oral and systemic health.

Another systemic condition with significant implications for periodontal disease is osteoporosis, a disorder characterized by reduced bone density. Osteoporotic patients are more susceptible to alveolar bone loss, which compromises the structural support of teeth, leading to increased tooth mobility and eventual tooth loss. This loss of bone density accelerates the progression of periodontal disease, as the weakened alveolar bone is less able to withstand the inflammatory destruction caused by periodontal pathogens. Hormonal changes, particularly in postmenopausal women, further exacerbate this process, leading to a higher incidence of periodontal disease in osteoporotic individuals.⁸ As the relationship between systemic diseases and periodontal health becomes increasingly clear, it is evident that successful periodontal management must consider these systemic factors to optimize outcomes.

Impact of metabolic and cardiovascular disorders on maxillofacial surgical outcomes

Systemic diseases such as diabetes, cardiovascular disease, and osteoporosis have a profound impact on periodontal health, contributing to the progression of periodontal disease and complicating treatment outcomes. Diabetes mellitus has been extensively studied in relation to periodontal disease. Diabetic patients exhibit a higher prevalence of periodontitis due to their impaired immune response, characterized by reduced neutrophil function and collagen synthesis, which are critical for maintaining periodontal health. Elevated blood glucose levels create an environment conducive to increased inflammation and delayed healing, exacerbating periodontal disease progression. Studies have shown that patients with poor glycemic control are more likely to suffer from severe periodontitis, making diabetes a major risk factor in periodontal disease progression.⁷

Cardiovascular diseases are also closely linked to periodontal health, with inflammation playing a central role in both conditions. Chronic periodontal infection triggers systemic inflammatory responses, which can aggravate cardiovascular conditions such as atherosclerosis. Research suggests that periodontal pathogens may enter the bloodstream, contributing to the formation of atherosclerotic plaques and promoting vascular inflammation. This bidirectional relationship underscores the importance of managing periodontal health to reduce the risk of cardiovascular events, as periodontal inflammation may further elevate systemic inflammatory markers such as C-reactive protein.³ The presence of periodontitis in individuals with cardiovascular disease has been associated with poorer prognoses, indicating the necessity of integrated care that addresses both oral and systemic health.

Another systemic condition with significant implications for periodontal disease is osteoporosis, a disorder characterized by reduced bone density. Osteoporotic patients are more susceptible to alveolar bone loss, which compromises the structural support of teeth, leading to increased tooth mobility and eventual tooth loss. This loss of bone density accelerates the progression of periodontal disease, as the weakened alveolar bone is less able to withstand the inflammatory destruction caused by periodontal pathogens. Hormonal changes, particularly in postmenopausal women, further exacerbate this process, leading to a higher incidence of periodontal disease in osteoporotic individuals.⁸ As the relationship between systemic diseases and periodontal health becomes increasingly clear, it is evident that successful periodontal management must consider these systemic factors to optimize outcomes.

The role of immunocompromised states in oral tissue healing and post-surgical recovery

Immunocompromised individuals, such as those with HIV/AIDS, undergoing chemotherapy, or receiving immunosuppressive treatments for conditions like organ transplantation, face significant challenges in oral tissue healing and post-surgical recovery. These patients have compromised immune systems, which impacts their ability to respond effectively to infections and heal after dental or maxillofacial surgery. One of the most critical factors is the impairment of immune cells, such as neutrophils and macrophages, that are essential for fighting infections and promoting tissue repair. In HIV-positive patients, for instance, the depletion of CD4+ T cells weaken the body's ability to mount an adequate immune response, resulting in higher susceptibility to oral infections like periodontitis and delayed wound healing following surgery.⁹

Chemotherapy, commonly used in cancer treatment, also has a profound effect on oral health and surgical recovery. Chemotherapeutic agents often target rapidly dividing cells, which includes not only cancer cells but also healthy cells in the oral mucosa. This leads to mucositis, a painful condition characterized by inflammation and ulceration of the mucous membranes. Additionally, the bone marrow suppression caused by chemotherapy reduces the production of white blood cells, further impairing the body's ability to fight infections.

Consequently, patients undergoing chemotherapy are more prone to postoperative complications, such as infection, dehiscence, and delayed healing, following maxillofacial surgeries.¹⁰ For instance, one of the most common oral infections in chemotherapy and radiotherapy patients is oral mucositis (Figure 1). Therefore, oral healthcare providers must adopt preventive measures and modify surgical protocols to mitigate these risks in immunocompromised patients.

Patients receiving long-term immunosuppressive therapy, such as organ transplant recipients, also experience delayed oral tissue healing and a higher risk of postoperative infections. Immunosuppressive drugs, such as corticosteroids and calcineurin inhibitors, are used to prevent organ rejection but have the side effect of suppressing the body’s natural immune response. This not only increases the risk of infections but also impairs collagen synthesis and wound contraction, leading to prolonged healing times and a higher likelihood of complications like wound dehiscence.¹² These patients often require a multidisciplinary approach, involving close collaboration between their medical and dental teams, to manage their oral health and surgical outcomes effectively.

The impact of systemic diseases on dental implant success

Systemic diseases such as diabetes, osteoporosis, and cardiovascular disorders significantly influence the success rate of dental implants, a crucial area of concern in dentistry. Dental implants rely on the process of osseointegration, where the bone integrates with the implant, providing stable support for prosthetic teeth. However, in patients with systemic conditions, this process can be impaired, leading to a higher risk of implant failure. Diabetes is one of the most well-documented systemic diseases that affect dental implant success. Hyperglycemia in diabetic patients interferes with osseointegration by impairing bone formation and wound healing. Research has shown that patients with poorly controlled diabetes have a higher risk of peri-implantitis, an inflammatory condition that affects the tissues surrounding dental implants, which can lead to implant failure.¹³ Additionally, the delayed healing process in diabetic individuals can complicate the postoperative period, increasing the likelihood of complications such as infection. Osteoporosis, a condition characterized by decreased bone density, also plays a significant role in dental implant outcomes. The quality and quantity of bone in osteoporotic patients are often insufficient to support the implant, leading to compromised stability. Studies indicate that osteoporotic patients may experience delayed or inadequate osseointegration, increasing the chances of implant failure, particularly in the long term.¹⁴ Bone augmentation procedures are sometimes required in these patients to improve the chances of successful implant integration, adding another layer of complexity to dental treatment. Cardiovascular diseases also pose challenges in dental implantology. Patients with cardiovascular conditions, particularly those on anticoagulant therapy, face a heightened risk of bleeding during and after implant surgery. Moreover, the systemic inflammation associated with cardiovascular diseases can interfere with the healing process and osseointegration, thereby reducing the long-term success of dental implants.¹⁵ Managing these patients requires a multidisciplinary approach, including the careful coordination of medical and dental care to optimize implant success while minimizing systemic risks.

CONCLUSION

Systemic diseases significantly impact oral health and the outcomes of maxillofacial surgery, particularly in patients with conditions such as diabetes, cardiovascular disorders, and immunosuppressive states. These diseases exacerbate periodontal disease progression, impair wound healing, and increase the risk of postoperative complications. A multidisciplinary approach that integrates medical management with dental care is crucial for optimizing treatment outcomes. Future research should continue to explore these relationships to develop tailored treatment protocols for patients with systemic conditions.

Funding: No funding sources

Conflict of interest: None declared

Ethical approval: Not required

REFERENCES

1. 1. Genco RJ, Borgnakke WS. Risk factors for periodontal disease. Periodontology 2000. 2013;62(1):59-94.
2. 2. Mealey BL, Oates TW. Diabetes mellitus and periodontal diseases. J Periodontol. 2006;77(8):1289-303.
3. 3. Lockhart PB, Bolger AF, Papapanou PN, Osinbowale O, Trevisan M, Levison ME, et al. Periodontal disease and atherosclerotic vascular disease: does the evidence support an independent association? A scientific statement from the American Heart Association. Circulation. 2012;125(20):2520-44.
4. 4. Weinert M, Grimes RM, Lynch DP. Oral manifestations of HIV infection. Ann Int Med. 1996;125(6):485-96.
5. 5. Taylor GW, Borgnakke WS. Periodontal disease: associations with diabetes, glycemic control and complications. Oral Dis. 2008;14(3):191-203.
6. 6. Dietrich T, Sharma P, Walter C, Weston P, Beck J. The epidemiological evidence behind the association between periodontitis and incident atherosclerotic cardiovascular disease. J Periodontol. 2013;84:S70-84.
7. 7. Löe H. Periodontal disease: the sixth complication of diabetes mellitus. Diabetes Care. 1993;16(1):329-34.
8. 8. Krall E, Garcia R, Dawson-Hughes B. Increased risk of tooth loss is related to bone loss at the whole body, hip, and spine. Calcified Tissue Int. 1996;59:433-7.
9. 9. Patton LL, McKaig R, Strauss R, Rogers D, Eron Jr JJ. Changing prevalence of oral manifestations of human immuno-deficiency virus in the era of protease inhibitor therapy. Oral Surg Oral Med Oral Pathol Oral Radiol Endodontol. 2000;89(3):299-304.
10. 10. Epstein JB, Silverman Jr S, Paggiarino DA, Crockett S, Schubert MM, Senzer NN, et al. Benzydamine HCl for prophylaxis of radiation‐induced oral mucositis: Results from a multicenter, randomized, double‐blind, placebo‐controlled clinical trial. Cancer. 2001;92(4):875-85.
11. 11. Elad S, Yarom N, Zadik Y, Kuten‐Shorrer M, Sonis ST. The broadening scope of oral mucositis and oral ulcerative mucosal toxicities of anticancer therapies. CA Cancer J Clin. 2022;72(1):57-77.
12. 12. Toma AI, Fuller JM, Willett NJ, Goudy SL. Oral wound healing models and emerging regenerative therapies. Transl Res. 2021;236:17-34.
13. 13. Molina CA, Ojeda LF, Jiménez MS, Portillo CM, Olmedo IS, Hernández TM, et al. Diabetes and periodontal diseases: An established two-way relationship. J Diabetes Mellitus. 2016;6(4):209-29.
14. 14. Zizzari VL, Zara S, Tetè G, Vinci R, Gherlone E, Cataldi A. Biologic and clinical aspects of integration of different bone substitutes in oral surgery: a literature review. Oral Surg Oral Med Oral Pathol Oral Radiol. 2016;122(4):392-402.
15. 15. Lalla E, Papapanou PN. Diabetes mellitus and periodontitis: a tale of two common interrelated diseases. Nat Rev Endocrinol. 2011;7(12):738-48.